Seth Alpna

EDGAR CIK 0001721020

Keros Therapeutics, Inc. - KROS

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director
Direct Buys
0
$0
0 Shares
Direct Sells
1
($28,140)
-2,625 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/04/2026
10b5-1
06/05/2026
Sell
-2,625 @ $10.72
 ($28,140) 9,767 (-21.18%) Direct